Literature DB >> 30957859

Comparison of outcomes of pulmonary valve replacement in adult versus paediatric hospitals: institutional influence†.

Stephanie Fuller1, Abhinay Ramachandran2, Katherine Awh3, Jennifer A Faerber4, Prakash A Patel5, Susan C Nicolson6, Michael L O'Byrne3, Christopher E Mascio1, Yuli Y Kim3,7.   

Abstract

OBJECTIVES: Controversy exists in ascertaining the ideal location for adults with congenital heart disease requiring surgical intervention. In this study, we sought to compare the perioperative management between our paediatric and adult hospitals and to determine how clinical factors and the location affect the length of stay after pulmonary valve replacement.
METHODS: A retrospective analysis of patients, ≥18 years of age, undergoing pulmonary valve replacement was conducted at our paediatric and adult hospitals between 1 January 2000 and 30 October 2014. Patients with previous Ross or concomitant left heart procedures were excluded. Descriptive statistics were used to assess demographics and clinical characteristics. Inverse probability weight-adjusted models were used to determine differences in the number of surgical complications, duration of mechanical ventilation and postoperative length of stay between paediatric and adult hospitals. Additional models were calculated to identify factors associated with prolonged length of stay.
RESULTS: There were altogether 98 patients in the adult (48 patients) and paediatric (50 patients) hospitals. Patients in the adult hospital were older with more comorbidities (arrhythmia, hypertension, depression and a history of cardiac arrest, all P < 0.05). Those at the paediatric hospital had better preoperative right ventricular function and less tricuspid regurgitation. The cardiopulmonary bypass time, the length of intubation and the length of stay were higher at the adult hospital, despite no difference in the number of complications between locations. Factors contributing to the increased length of stay include patient characteristics and postoperative management strategies. There were no deaths.
CONCLUSIONS: Pulmonary valve replacement may be performed safely with no deaths and with a comparable complication rate at both hospitals. Patients undergoing surgery at the adult hospital have longer intubation times and length of stay. Opportunities exist to streamline management strategies.
© The Author(s) 2019. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Entities:  

Keywords:  Adult congenital heart disease; Congenital heart disease; Outcomes

Year:  2019        PMID: 30957859      PMCID: PMC6886565          DOI: 10.1093/ejcts/ezz102

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  24 in total

1.  Resource use among adult congenital heart surgery admissions in pediatric hospitals: risk factors for high resource utilization and association with inpatient death.

Authors:  Yuli Y Kim; Kimberlee Gauvreau; Emile A Bacha; Michael J Landzberg; Oscar J Benavidez
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2011-10-18

2.  Estimating Mortality Risk for Adult Congenital Heart Surgery: An Analysis of The Society of Thoracic Surgeons Congenital Heart Surgery Database.

Authors:  Stephanie M Fuller; Xia He; Jeffrey P Jacobs; Sara K Pasquali; J William Gaynor; Christopher E Mascio; Kevin D Hill; Marshall L Jacobs; Yuli Y Kim
Journal:  Ann Thorac Surg       Date:  2015-09-26       Impact factor: 4.330

Review 3.  The nomenclature of safety and quality of care for patients with congenital cardiac disease: a report of the Society of Thoracic Surgeons Congenital Database Taskforce Subcommittee on Patient Safety.

Authors:  Jeffrey Phillip Jacobs; Oscar J Benavidez; Emile A Bacha; Henry L Walters; Marshall Lewis Jacobs
Journal:  Cardiol Young       Date:  2008-12       Impact factor: 1.093

4.  Risk factors for death after adult congenital heart surgery in pediatric hospitals.

Authors:  Yuli Y Kim; Kimberlee Gauvreau; Emile A Bacha; Michael J Landzberg; Oscar J Benavidez
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2011-06-21

Review 5.  Estimating causal effects from large data sets using propensity scores.

Authors:  D B Rubin
Journal:  Ann Intern Med       Date:  1997-10-15       Impact factor: 25.391

6.  Prolonged mechanical ventilation after cardiac surgery: outcome and predictors.

Authors:  Jean-Louis Trouillet; Alain Combes; Elisabeth Vaissier; Charles-Edouard Luyt; Alexandre Ouattara; Alain Pavie; Jean Chastre
Journal:  J Thorac Cardiovasc Surg       Date:  2009-07-10       Impact factor: 5.209

7.  Perioperative care of the adult with congenital heart disease in a free-standing tertiary pediatric facility.

Authors:  A R Mott; C D Fraser; E D McKenzie; L I Bezold; D B Andropoulos; G J Reul; C H Miranda; S L Bedford; T F Feltes
Journal:  Pediatr Cardiol       Date:  2002 Nov-Dec       Impact factor: 1.655

8.  Cardiac surgery in adults performed at children's hospitals: trends and outcomes.

Authors:  William T Mahle; Paul M Kirshbom; Kirk R Kanter; Brian M Kogon
Journal:  J Thorac Cardiovasc Surg       Date:  2008-08       Impact factor: 5.209

9.  Effectiveness of dexmedetomidine versus propofol on extubation times, length of stay and mortality rates in adult cardiac surgery patients: a systematic review and meta-analysis.

Authors:  John Nguyen; Noel Nacpil
Journal:  JBI Database System Rev Implement Rep       Date:  2018-05

10.  Cost comparison of Transcatheter and Operative Pulmonary Valve Replacement (from the Pediatric Health Information Systems Database).

Authors:  Michael L O'Byrne; Matthew J Gillespie; Russell T Shinohara; Yoav Dori; Jonathan J Rome; Andrew C Glatz
Journal:  Am J Cardiol       Date:  2015-10-17       Impact factor: 2.778

View more
  1 in total

1.  Outcomes of Operator-Directed Sedation and Anesthesiologist Care in the Pediatric/Congenital Catheterization Laboratory: A Study Utilizing Data From the IMPACT Registry.

Authors:  Michael L O'Byrne; Kevin F Kennedy; James M Steven; Kevin D Hill; Reid C Chamberlain; Marisa E Millenson; Christopher L Smith; Yoav Dori; Matthew J Gillespie; Jonathan J Rome; Andrew C Glatz
Journal:  JACC Cardiovasc Interv       Date:  2021-02-22       Impact factor: 11.195

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.